Your browser doesn't support javascript.
loading
Healthcare resource use of patients with transthyretin amyloid cardiomyopathy.
Lauppe, Rosa; Liseth Hansen, Johan; Fornwall, Anna; Johansson, Katarina; Rozenbaum, Mark H; Strand, Anne Mette; Vakevainen, Merja; Kuusisto, Johanna; Gude, Einar; Smith, J Gustav; Gustafsson, Finn.
Afiliação
  • Lauppe R; Quantify Research AB, Stockholm, 112 21, Sweden.
  • Liseth Hansen J; Quantify Research AB, Stockholm, 112 21, Sweden.
  • Fornwall A; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Johansson K; Quantify Research AB, Stockholm, 112 21, Sweden.
  • Rozenbaum MH; Pfizer AB, Stockholm, Sweden.
  • Strand AM; Pfizer, Inc., Capelle aan den IJssel, The Netherlands.
  • Vakevainen M; Pfizer Denmark ApS, Ballerup, Denmark.
  • Kuusisto J; Pfizer Oy, Helsinki, Finland.
  • Gude E; Department of Medicine and Clinical Research, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland.
  • Smith JG; Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Gustafsson F; Department of Cardiology, Wallenberg Center for Molecular Medicine and Lund University Diabetes Center, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden.
ESC Heart Fail ; 9(3): 1636-1642, 2022 06.
Article em En | MEDLINE | ID: mdl-35365974

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuropatias Amiloides Familiares / Insuficiência Cardíaca / Cardiomiopatias Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuropatias Amiloides Familiares / Insuficiência Cardíaca / Cardiomiopatias Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article